Nisa Investment Advisors
CNCE

Nisa Investment Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Nisa Investment Advisors’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-910
Closed -$4 – 2350
2021
Q2 		$4 Hold
910
– – ﹤0.01% 2288
2021
Q1 		$5 Hold
910
– – ﹤0.01% 2260
2020
Q4 		$12K Buy
910
+100
+12% +$1.14K ﹤0.01% 2198
2020
Q3 		$8K Sell
810
-320
-28% -$3.15K ﹤0.01% 2152
2020
Q2 		$11K Buy
1,130
+690
+157% +$6.62K ﹤0.01% 1908
2020
Q1 		$4K Buy
+440
New +$4.34K ﹤0.01% 1988

Other funds holding CNCE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Nisa Investment Advisors's CNCE Position: Q3 2021 in Review

Nisa Investment Advisors sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2021, closing a stake of 910 shares — an estimated $4 sold.

Nisa Investment Advisors first reported a position in CNCE in Q1 2020 and held it in 6 quarters. The position peaked at $12K in Q4 2020. 61 funds tracked by Wall St. Rank hold CNCE as of Q3 2021.

  • Nisa Investment Advisors reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Nisa Investment Advisors sold 910 Concert Pharmaceuticals, Inc. shares in Q3 2021, an estimated $4.
  • Nisa Investment Advisors first reported a position in Concert Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
  • Nisa Investment Advisors's Concert Pharmaceuticals, Inc. position peaked at $12K in Q4 2020.
  • 61 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2021.

Based on Nisa Investment Advisors's 13F filing for Q3 2021, filed 18 Oct 2021.